US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antibody-drug Conjugate market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antibody-drug Conjugate market." Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugsdesigned as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells. The global Antibody-drug Conjugate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Antibody-drug Conjugate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Agensys Concortis Biotherapeutics Sanofi Celldex Therapeutics Synthon Holding BV ... Segment by Regions North America Europe China Japan Segment by Type Adcetris Kadcyla Segment by Application Breast Cancer Lymphoma
Table of Contents Executive Summary 1 Antibody-drug Conjugate Market Overview 1.1 Product Overview and Scope of Antibody-drug Conjugate 1.2 Antibody-drug Conjugate Segment by Type 1.2.1 Global Antibody-drug Conjugate Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Adcetris 1.2.3 Kadcyla 1.3 Antibody-drug Conjugate Segment by Application 1.3.1 Antibody-drug Conjugate Consumption Comparison by Application (2014-2025) 1.3.2 Breast Cancer 1.3.3 Lymphoma 1.4 Global Antibody-drug Conjugate Market by Region 1.4.1 Global Antibody-drug Conjugate Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Antibody-drug Conjugate Market Size 1.5.1 Global Antibody-drug Conjugate Revenue (2014-2025) 1.5.2 Global Antibody-drug Conjugate Production (2014-2025) 2 Global Antibody-drug Conjugate Market Competition by Manufacturers 2.1 Global Antibody-drug Conjugate Production Market Share by Manufacturers (2014-2019) 2.2 Global Antibody-drug Conjugate Revenue Share by Manufacturers (2014-2019) 2.3 Global Antibody-drug Conjugate Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Antibody-drug Conjugate Production Sites, Area Served, Product Types 2.5 Antibody-drug Conjugate Market Competitive Situation and Trends 2.5.1 Antibody-drug Conjugate Market Concentration Rate 2.5.2 Antibody-drug Conjugate Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Antibody-drug Conjugate Production Market Share by Regions 3.1 Global Antibody-drug Conjugate Production Market Share by Regions 3.2 Global Antibody-drug Conjugate Revenue Market Share by Regions (2014-2019) 3.3 Global Antibody-drug Conjugate Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Antibody-drug Conjugate Production 3.4.1 North America Antibody-drug Conjugate Production Growth Rate (2014-2019) 3.4.2 North America Antibody-drug Conjugate Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Antibody-drug Conjugate Production 3.5.1 Europe Antibody-drug Conjugate Production Growth Rate (2014-2019) ... | read more...